<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Enterobacter aerogenes | UTI PathoDB</title>
  <script src="https://cdn.tailwindcss.com"></script>
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
</head>
<body class="bg-gray-50 text-gray-800">

  <!-- Navbar -->
  <nav class="bg-blue-900 text-white p-4">
    <div class="container mx-auto flex justify-between items-center">
      <a href="../index.html" class="text-xl font-bold text-teal-300 flex items-center">
        <i class="fas fa-bacteria mr-2"></i> UTI PathoDB
      </a>
      <ul class="flex space-x-6">
        <li><a href="../index.html" class="hover:text-teal-300">Home</a></li>
        <li><a href="../uti-info.html" class="hover:text-teal-300">UTI Info</a></li>
      </ul>
    </div>
  </nav>

  <!-- Header -->
  <header class="bg-teal-600 text-white py-12 text-center">
    <h1 class="text-4xl font-bold">Enterobacter aerogenes</h1>
    <p class="text-lg opacity-90">A Gram-negative bacterium associated with hospital-acquired infections, especially in immunocompromised hosts</p>
  </header>

  <!-- Main Content -->
  <main class="py-10 px-6 max-w-6xl mx-auto space-y-12">
    
    <!-- Overview -->
    <section>
      <h2 class="text-2xl font-semibold text-blue-800 mb-4"><i class="fas fa-info-circle text-teal-500 mr-2"></i> Overview</h2>
      <p>
        <em>Enterobacter aerogenes</em> is an opportunistic pathogen known for causing nosocomial infections such as urinary tract infections, bloodstream infections, and respiratory tract infections. Its multidrug resistance makes treatment challenging in healthcare settings.
      </p>
    </section>

    <!-- Molecular Markers -->
    <section>
      <h2 class="text-2xl font-semibold text-blue-800 mb-4"><i class="fas fa-dna text-teal-500 mr-2"></i> Molecular Markers</h2>
      <ul class="list-disc pl-5 space-y-1">
        <li>Extended-Spectrum Beta-Lactamases (ESBL) production conferring resistance to beta-lactam antibiotics</li>
        <li>Carbapenemase enzymes leading to carbapenem resistance</li>
        <li>Efflux pump mechanisms reducing intracellular antibiotic concentration</li>
        <li>Biofilm formation contributing to persistence on medical devices</li>
      </ul>
    </section>

    <!-- Immune Response -->
    <section>
      <h2 class="text-2xl font-semibold text-blue-800 mb-4"><i class="fas fa-shield-virus text-teal-500 mr-2"></i> Immune Response</h2>
      <p>
        Host immune response includes neutrophil-mediated clearance. Biofilm production and multidrug resistance mechanisms help the bacteria evade immune detection and destruction, complicating infections in immunocompromised patients.
      </p>
    </section>

    <!-- Epidemiology -->
    <section>
      <h2 class="text-2xl font-semibold text-blue-800 mb-4"><i class="fas fa-chart-line text-teal-500 mr-2"></i> Epidemiology</h2>
      <ul class="list-disc pl-5 space-y-1">
        <li>Frequently isolated in hospital settings, particularly ICUs</li>
        <li>Common in patients with invasive devices such as catheters and ventilators</li>
        <li>Higher infection rates in immunocompromised individuals</li>
      </ul>
    </section>

    <!-- References -->
    <section>
      <h2 class="text-2xl font-semibold text-blue-800 mb-4"><i class="fas fa-book text-teal-500 mr-2"></i> References</h2>
      <ul class="list-disc pl-5">
        <li>ASM Journals</li>
      </ul>
    </section>

  </main>
</body>
</html>
